首页> 外文期刊>Journal of Hainan Medical University >Clinical observation of Jiangzhi Hugan Recipe combined with rosuvastatin calcium tablets in the treatment of non-alcoholic fatty liver disease
【24h】

Clinical observation of Jiangzhi Hugan Recipe combined with rosuvastatin calcium tablets in the treatment of non-alcoholic fatty liver disease

机译:降脂护肝方联合瑞舒伐他汀钙片治疗非酒精性脂肪肝的临床观察

获取原文
       

摘要

Objective: To investigate the influence of integrated traditional Chinese and Western medicineon the related indexes and TCM syndrome scores of patients with non-alcoholic fatty liverdisease. Methods: A total of 128 patients with non-alcoholic fatty liver disease who wereadmitted to our department from January 2017 to May 18, 2017 were enrolled in the study.According to the hospital admission record number, they were randomly divided intotreatment groups (64 cases). and the control group (64 cases). The control group was treatedwith rosuvastatin calcium tablets. The treatment group was treated with Jiangzhi FangganRecipe on the basis of the control group. The treatment was performed for 10 d for a total of3 courses. Comparison of liver function, blood lipids, insulin resistance index (HOMA-IR),iris (Irisin), superoxide dismutase (SOD), malondialdehyde (MDA), body mass index (BMI),waist circumference (WC), Liver/spleen CT ratio and TCM syndrome scores. Results: Thecurative effect of TCM symptom in the treatment group (82.82%) was significantly higherthan that in the control group (65.62%), and the difference was statistically significant. Therewas no difference between the two groups before treatment. Compared with before treatment,the levels of each index were significantly improved after treatment, and the improvementof the treatment group was more significant than that of the control group. Conclusion: Thecombination of traditional Chinese and Western medicine can improve the symptoms ofpatients, achieve good clinical efficacy, and have certain anti-oxidative stress effects, which isworthy of clinical promotion or further research.
机译:目的:探讨中西医结合治疗对非酒精性脂肪性肝病患者相关指标和中医证候评分的影响。方法:纳入2017年1月至2017年5月18日收治的我院非酒精性脂肪肝病患者128例,根据入院记录号随机分为治疗组(64例)。 )。对照组(64例)。对照组接受瑞舒伐他汀钙片治疗。治疗组在对照组的基础上给予降脂防感方治疗。治疗进行了10天,共3个疗程。肝功能,血脂,胰岛素抵抗指数(HOMA-IR),虹膜(Irisin),超氧化物歧化酶(SOD),丙二醛(MDA),体重指数(BMI),腰围(WC),肝/脾CT的比较比率和中医证候评分。结果:治疗组中医证候疗效(82.82%)明显高于对照组(65.62%),差异有统计学意义。两组治疗前无差异。与治疗前相比,治疗后各项指标水平均有明显提高,治疗组的改善比对照组显着。结论:中西医结合治疗可改善患者症状,取得良好的临床疗效,并具有一定的抗氧化应激作用,值得临床推广或进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号